BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33000236)

  • 1. YAP‑mediated crosstalk between the Wnt and Hippo signaling pathways (Review).
    Jiang L; Li J; Zhang C; Shang Y; Lin J
    Mol Med Rep; 2020 Nov; 22(5):4101-4106. PubMed ID: 33000236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
    Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
    Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP and TAZ Take Center Stage in Cancer.
    Zhang K; Qi HX; Hu ZM; Chang YN; Shi ZM; Han XH; Han YW; Zhang RX; Zhang Z; Chen T; Hong W
    Biochemistry; 2015 Nov; 54(43):6555-66. PubMed ID: 26465056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review.
    Crawford JJ; Bronner SM; Zbieg JR
    Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112
    [No Abstract]   [Full Text] [Related]  

  • 6. RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73.
    Papaspyropoulos A; Bradley L; Thapa A; Leung CY; Toskas K; Koennig D; Pefani DE; Raso C; Grou C; Hamilton G; Vlahov N; Grawenda A; Haider S; Chauhan J; Buti L; Kanapin A; Lu X; Buffa F; Dianov G; von Kriegsheim A; Matallanas D; Samsonova A; Zernicka-Goetz M; O'Neill E
    Nat Commun; 2018 Jan; 9(1):424. PubMed ID: 29382819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size.
    Heallen T; Zhang M; Wang J; Bonilla-Claudio M; Klysik E; Johnson RL; Martin JF
    Science; 2011 Apr; 332(6028):458-61. PubMed ID: 21512031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of TP73 transcription by Hippo-YAP signaling.
    Wen Z; Wang Y; Qi S; Ma M; Li J; Yu FX
    Biochem Biophys Res Commun; 2020 Oct; 531(2):96-104. PubMed ID: 32773110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
    Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
    J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of extracellular matrix and YAP/TAZ in cell fate determination.
    Hao J; Zhang Y; Wang Y; Ye R; Qiu J; Zhao Z; Li J
    Cell Signal; 2014 Feb; 26(2):186-91. PubMed ID: 24216612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.
    Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X
    PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
    Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
    Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifaceted regulation and functions of YAP/TAZ in tumors (Review).
    Liu H; Du S; Lei T; Wang H; He X; Tong R; Wang Y
    Oncol Rep; 2018 Jul; 40(1):16-28. PubMed ID: 29749524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt signaling promotes androgen-independent prostate cancer cell proliferation through up-regulation of the hippo pathway effector YAP.
    Seo WI; Park S; Gwak J; Ju BG; Chung JI; Kang PM; Oh S
    Biochem Biophys Res Commun; 2017 May; 486(4):1034-1039. PubMed ID: 28366633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Crosstalk of Hippo/YAP and Wnt/β-catenin pathways].
    Xu F; Zhang J; Ma D
    Yi Chuan; 2014 Feb; 36(2):95-102. PubMed ID: 24846937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways.
    Karvonen H; Barker H; Kaleva L; Niininen W; Ungureanu D
    Cells; 2019 Aug; 8(8):. PubMed ID: 31382410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IQGAP1 Binds to Yes-associated Protein (YAP) and Modulates Its Transcriptional Activity.
    Sayedyahossein S; Li Z; Hedman AC; Morgan CJ; Sacks DB
    J Biol Chem; 2016 Sep; 291(37):19261-73. PubMed ID: 27440047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.
    Zhou Z; Hu T; Xu Z; Lin Z; Zhang Z; Feng T; Zhu L; Rong Y; Shen H; Luk JM; Zhang X; Qin N
    FASEB J; 2015 Feb; 29(2):724-32. PubMed ID: 25384421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of intersignaling crosstalk on the intracellular localization of YAP/TAZ in lung cells.
    Govorova IA; Nikitochkina SY; Vorotelyak EA
    Cell Commun Signal; 2024 May; 22(1):289. PubMed ID: 38802925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of Hippo-YAP Signaling with Metabolism.
    Ibar C; Irvine KD
    Dev Cell; 2020 Jul; 54(2):256-267. PubMed ID: 32693058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.